Studies of the Mortality of Atomic Bomb Survivors, Report 14, 1950–2003: An Overview of Cancer and Noncancer Diseases

This is the 14th report in a series of periodic general reports on mortality in the Life Span Study (LSS) cohort of atomic bomb survivors followed by the Radiation Effects Research Foundation to investigate the late health effects of the radiation from the atomic bombs. During the period 1950–2003, 58% of the 86,611 LSS cohort members with DS02 dose estimates have died. The 6 years of additional follow-up since the previous report provide substantially more information at longer periods after radiation exposure (17% more cancer deaths), especially among those under age 10 at exposure (58% more deaths). Poisson regression methods were used to investigate the magnitude of the radiation-associated risks, the shape of the dose response, and effect modification by gender, age at exposure, and attained age. The risk of all causes of death was positively associated with radiation dose. Importantly, for solid cancers the additive radiation risk (i.e., excess cancer cases per 104 person-years per Gy) continues to increase throughout life with a linear dose–response relationship. The sex-averaged excess relative risk per Gy was 0.42 [95% confidence interval (CI): 0.32, 0.53] for all solid cancer at age 70 years after exposure at age 30 based on a linear model. The risk increased by about 29% per decade decrease in age at exposure (95% CI: 17%, 41%). The estimated lowest dose range with a significant ERR for all solid cancer was 0 to 0.20 Gy, and a formal dose-threshold analysis indicated no threshold; i.e., zero dose was the best estimate of the threshold. The risk of cancer mortality increased significantly for most major sites, including stomach, lung, liver, colon, breast, gallbladder, esophagus, bladder and ovary, whereas rectum, pancreas, uterus, prostate and kidney parenchyma did not have significantly increased risks. An increased risk of non-neoplastic diseases including the circulatory, respiratory and digestive systems was observed, but whether these are causal relationships requires further investigation. There was no evidence of a radiation effect for infectious or external causes of death.

[1]  M Blettner,et al.  Is cancer risk of radiation workers larger than expected? , 2009, Occupational and Environmental Medicine.

[2]  J H FOLLEY,et al.  Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan. , 1952, The American journal of medicine.

[3]  N. E. Breslow Statistical Methods in Cancer Research , 1986 .

[4]  Division on Earth Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2 , 2006 .

[5]  S. Jablon,et al.  STUDIES OF THE MORTALITY OF A-BOMB SURVIVORS. 3. DESCRIPTION OF THE SAMPLE AND MORTALITY, 1950--1960. , 1965, Radiation research.

[6]  H. Sugiyama,et al.  Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003 , 2010, BMJ : British Medical Journal.

[7]  K. Chayama,et al.  Impact of radiation and hepatitis virus infection on risk of hepatocellular carcinoma , 2011, Hepatology.

[8]  G. Beebe,et al.  Studies of the Mortality of A-Bomb Survivors: 6. Mortality and Radiation Dose, 1950-1974 , 1971 .

[9]  岩崎 民子 SOURCES AND EFFECTS OF IONIZING RADIATION : United Nations Scientific Committee on the Effects of Atomic Radiation UNSCEAR 2000 Report to the General Assembly, with Scientific Annexes , 2002 .

[10]  D L Preston,et al.  Studies of the mortality of A-bomb survivors. 8. Cancer mortality, 1950-1982. , 1987, Radiation research.

[11]  D A Pierce,et al.  Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. , 1996, Radiation research.

[12]  Norman E. Breslow,et al.  The design and analysis of cohort studies , 1987 .

[13]  Charles Mw,et al.  Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. , 2003 .

[14]  H. Dohy,et al.  Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. , 1994, Radiation research.

[15]  Yukiko Shimizu,et al.  Effect of Recent Changes in Atomic Bomb Survivor Dosimetry on Cancer Mortality Risk Estimates , 2004, Radiation research.

[16]  Sachiyo Funamoto,et al.  Dose Estimation for Atomic Bomb Survivor Studies: Its Evolution and Present Status , 2006, Radiation research.

[17]  D. Pierce,et al.  Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. , 1990, Radiation research.

[18]  D. Richardson,et al.  Ionizing Radiation and Leukemia Mortality among Japanese Atomic Bomb Survivors, 1950–2000 , 2009, Radiation research.

[19]  Enrique Egaña,et al.  Effects of Ionizing Radiation , 1971 .

[20]  Yukiko Shimizu,et al.  Studies of the Mortality of Atomic Bomb Survivors.Report 12, Part I. Cancer: 1950–1990 , 2012, Radiation research.

[21]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.

[22]  M. Little Heterogeneity of variation of relative risk by age at exposure in the Japanese atomic bomb survivors , 2009, Radiation and environmental biophysics.

[23]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[24]  S. Jablon,et al.  Studies of the Mortality of A-Bomb Survivors: I. Plan of Study and Mortality in the Medical Subsample (Selection I), 1950-1958 , 1962 .

[25]  D. Preston,et al.  Impact of comparison group on cohort dose response regression: an example using risk estimation in atomic-bomb survivors. , 2001, Health physics.

[26]  T. Mizuno,et al.  Hepatocellular carcinoma among atomic bomb survivors: Significant interaction of radiation with hepatitis C virus infections , 2003, International journal of cancer.

[27]  L. Walsh Heterogeneity of variation of relative risk by age at exposure in the Japanese atomic bomb survivors , 2009, Radiation and environmental biophysics.

[28]  D A Pierce,et al.  Studies of the mortality of atomic bomb survivors. Report 12, part II. Noncancer mortality: 1950-1990. , 1999, Radiation research.

[29]  V. Ovcharov [International classification of diseases (tenth revision)]. , 1998, Problemy sotsial'noi gigieny i istoriia meditsiny.

[30]  D. Richardson,et al.  Positive associations between ionizing radiation and lymphoma mortality among men. , 2009, American journal of epidemiology.

[31]  H. Akaike A new look at the statistical model identification , 1974 .

[32]  J. DiSantostefano,et al.  International Classification of Diseases 10th Revision (ICD-10) , 2009 .

[33]  M W Charles Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. , 2003, Journal of radiological protection : official journal of the Society for Radiological Protection.

[34]  Dale L Preston,et al.  Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. , 2008, Journal of the National Cancer Institute.

[35]  D. L. Preston,et al.  Solid Cancer Incidence in Atomic Bomb Survivors: 1958–1998 , 2007, Radiation research.

[36]  D. Preston,et al.  Radiation and Smoking Effects on Lung Cancer Incidence among Atomic Bomb Survivors , 2010, Radiation research.

[37]  Dale L Preston,et al.  Longevity of atomic-bomb survivors , 2000, The Lancet.

[38]  K. Kupka,et al.  International classification of diseases: ninth revision. , 1978, WHO chronicle.